Clinical Trials for Idera Pharmaceuticals

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Idera Pharmaceuticals

Clinical Trials (2)

NCT04126876
A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma
PHASE2Recruiting
214 participants
Started: Jan 22, 2020 · Completed: Nov 1, 2031
1 condition2 sponsors1 location
NCT03865082
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
PHASE2Active, not recruiting
30 participants
Started: Oct 29, 2019 · Completed: Apr 30, 2022
1 condition2 sponsors3 locations